儿科弗莱卡尼尼德药物基因组学:为儿科心律不整提供基于精度的护理的路线图
Ronald Palmen1, Mollie Walton1,2,3, Jonathan Wagner1,2,3
1Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO, United States.
Frontiers in pharmacology
|January 1, 2025
概括
弗莱卡因酸是一种抗心律失常药物,由于其狭窄的治疗指数,需要个性化剂量. 遗传变异会影响其有效性,特别是在儿童中,因此需要对儿科弗莱卡尼尼德治疗进行进一步研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
- 儿科 儿科 儿科
背景情况:
- 弗莱卡因酸是一种1c类抗失律药物.
- 它通过强大的通道阻塞起作用,治疗儿童和成年人的心律失常症.
- 它狭窄的治疗指数需要个性化药物治疗.
研究的目的:
- 审查弗莱卡尼德的处置和反应途径.
- 为了确定关于弗莱卡因治疗中的遗传变异的知识差距.
- 突出儿童用弗莱卡尼尼德的未来研究领域.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 对弗莱卡尼德的药理动力学和药理动力学途径的分析.
- 检查影响药物反应的遗传因素.
主要成果:
- 遗传变异性显著影响弗莱卡尼德的处置和反应.
- 由于药物代谢途径未成熟,儿童患者面临着独特的挑战.
- 目前存在关于儿科患者基因药物相互作用的知识差距.
结论:
- 个性化弗莱卡尼德疗法至关重要.
- 需要进一步研究儿童对弗莱卡尼德的遗传影响.
- 了解这些因素将优化儿科抗心律不良治疗.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
900
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
900
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
41
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
41
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
80
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
80
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707


